|
| Model Number: | LYSM |
| MOQ: | 1 unit |
| Price: | 10,000-50,000 USD per piece |
| Payment Terms: | T/T,Western Union,MoneyGram |
| Supply Ability: | 5 pcs per Month |
Automated Vial Capping Machine For Sterile Pharmaceutical Packaging, High Seal Accuracy And ISO Compliance
Revolutionize Your Sterile Packaging with Precision and Speed
In the high-stakes world of sterile pharmaceutical packaging, the Automated Vial Capping Machine stands as a game-changer. Designed to seamlessly integrate with vial filling lines, this cutting-edge equipment ensures airtight sealing for sensitive medications like vaccines, biologics, and insulin injections.
Why Choose Our Vial Capping Machine?
✅ Unmatched Seal Integrity: Achieve 99.9% capping accuracy with servo-driven torque control, eliminating leakage risks for oxygen-sensitive drugs like monoclonal antibodies.
✅ Zero Contamination Risks: Equipped with ISO 5-grade laminar airflow systems, it maintains a sterile environment critical for GMP-compliant production.
✅ Smart Adaptability: Handles 2-500ml vials effortlessly—ideal for small-batch personalized medicines or large-scale vaccine campaigns.
✅ Energy-Efficient Performance: Operates at 350W power with auto-diagnostic sensors to reduce downtime and energy waste.
Automated Vial Capping Machine Spec:
| Bottle Spec | 50-1000 ml glass or plastic bottles(need to change parts for different bottles) |
| Production Capacity | 100-300 bottles/min(need to change mold for differnt size) |
| Stoppering Head Qty. | 12 or more(customizable) |
| Stoppering Head Qty. | 12 or more(customizable) |
| PASS Rate of hanging plugs | >99% |
| PASS Rate of stoppering | >99% |
| Air Consumption and Pressure | 03-0.6 Mpa / 5-10 cbm/h |
| Stoppering Accuracy | < +/- 1% |
| Weight | 700Kg |
| Total Power | about 4.5KW 380V 50Hz |
| Size | 1700mm L x 1560mm W x 1780mm H |
Innovative Features That Set Us Apart
Applications Spotlight
Upgrade Your Production Today
From R&D labs to contract manufacturing hubs, our Automated Vial Capping Machine delivers faster throughput (15-70 vials/min) and zero human intervention—perfect for pharma giants aiming to dominate Middle Eastern and EU markets.
